65
Glomerular Disease s in Children Lectur er Xin Yue TIANJIN MEDICAL UNIVERSITY PEDIATRIC DPT. GENERAL HOSPITAL

Nephrosis 2009,

Embed Size (px)

Citation preview

Page 1: Nephrosis 2009,

Glomerular Diseases in Children

Lecturer

Xin YueTIANJIN MEDICAL UNIVERSITY

PEDIATRIC DPT.

GENERAL HOSPITAL

Page 2: Nephrosis 2009,

Nephrotic syndromeNephrotic syndrome

(NS)

Page 3: Nephrosis 2009,

Introduction

The nephrotic syndrome (NS) is characterized by

Edema EdemaHypercholesterolemia

(greater than 5.72 mmol/L)

Hypercholesterolemia (greater than 5.72

mmol/L)

Hypoalbuminemia

(less than 30 g/L)

Hypoalbuminemia

(less than 30 g/L)

Severe proteinuria

(greater than

0.05/kg/24hr)

Severe proteinuria

(greater than

0.05/kg/24hr)

Page 4: Nephrosis 2009,

Secondary

nephrosis

Secondary

nephrosis

Primary nephrotic syndrome(90%)Primary nephrotic syndrome(90%)

Types of nephrotic syndrome

Congenital

nephrosis

Congenital

nephrosis

Simple

nephrosisSimple

nephrosis

Nephritic

nephrosisNephritic

nephrosis

Page 5: Nephrosis 2009,

Etiology

Remains unknown

Several hypotheses

Abnormalities in the function of thymus-

derived (T-cell) lymphocytes

Specific HLA antigens

Complement deficiencies

Atopy

Page 6: Nephrosis 2009,

PathologyFive Morphologic Patterns:

Minimal-change disease (MCNS) (78%-85%) Focal segmental glomerulosclerosis (FSGS) (6.7%-10%) Mesangial proliferative glomerulonephritis (MsPG

N) (5%) Membranous glomerulopathy (MGN) (commonly occur

s in adults) Membranoproliferative glomerulonephritis (MPGN)

Page 7: Nephrosis 2009,

Features of MCD:LM - appear normal or show minimal incre

ase in mesangial cells and matrix.

IF – typically negative.

EM - effacement of foot processes.

More than 95% of children with MCNS are sensitive to corticosteroid therapy.

Minimal-change DiseaseMinimal-change Disease

Page 8: Nephrosis 2009,
Page 9: Nephrosis 2009,
Page 10: Nephrosis 2009,

Normal Foot ProcessesNormal Foot Processes

Effacement of Effacement of Foot ProcessesFoot Processes

Page 11: Nephrosis 2009,
Page 12: Nephrosis 2009,
Page 13: Nephrosis 2009,
Page 14: Nephrosis 2009,

MGN: Mildly Thickened Capillary LoopsMGN: Mildly Thickened Capillary Loops

Page 15: Nephrosis 2009,
Page 16: Nephrosis 2009,
Page 17: Nephrosis 2009,
Page 18: Nephrosis 2009,

Pathophysiology

• Proteinuria

• Hypoproteinemia

• Edema

• Hyperlipidemia

Page 19: Nephrosis 2009,

Normally, the charge and size selective barrier of the glomerular capillary wall (GCW) prevents filtration of plasma proteins with negative charges or large molecular weight.

In patients with NS, the structural changes: (1) damage to the endothelial surface, causing loss of the negative charge. (2) damage to the GBM

(3) effacement of the foot processes. leading to increased GCW permeability large amounts of protein (primarily albumin) cross the b

arrier and are excreted.

Proteinuria(1)

Proteinuria(1)

Page 20: Nephrosis 2009,

(Highly) selective proteinuria: the damage of glomeruli is mild and the permeabili

ty of GBM would be selectively altered, increasing capillary transport of anionically c

harged particles (albumin et al)Non- selective proteinuria: injuries of the glomeruli are severe both smal

l(albumin, transferrin) and large proteins (α2- macroglobulin, et al) can pass through the GBM and appear in urine.

Proteinuria(2)

Proteinuria(2)

Page 21: Nephrosis 2009,

Filtration slit membrane

fenestrations

Epithelial foot processes lamina rara externa lamina densa GBM lamina rara interna

capillary endothelium

glomerular filter membrane

Page 22: Nephrosis 2009,

The glomerular capillary wall:

Charge selective filter

The glomerular capillary wall:

Size selective filter

Page 23: Nephrosis 2009,

• Increased urinary loss of proteins is the main cause.

Other factors: The capacity to increase hepatic synthesis appears insufficient to compensate for the large urinary losses. Increaed protein catabolism. Some plasma protein levels are actually increased in NS

increased and relatively unregulated hepatic production of protein in response to hypoalbuminemia.

Hypoproteinemia(1)Hypoproteinemia(1)

Page 24: Nephrosis 2009,

Like albumin, the concertration of other plasma proteins are decreased:

IgG and some components of complememt decreased immunity Some anti-coagulant factors hypercoagulability state Vitamin D combining protein hypocalcemia Transferrin anemia

Hypoproteinemia(2)Hypoproteinemia(2)

Page 25: Nephrosis 2009,

• Hypoalbuminemia lowers the plasma colloid osmotic pressure with extravasation of plasma water into the interstitial space.

• The reduction in intravascular volume leads to: (1) A decrease in renal perfusion which stimulates the renin-angiotensin-aldosterone system (2) An increase in the synthesis and secretion of antidiuretic hormone(ADH)

Retention of both sodium and water

Edema(1)Edema(1)

Traditional opinions:

Page 26: Nephrosis 2009,

a primary renal disturbance (reduced GFR)

primary renal retention of sodium and waterexpansion of plasma suppression of the renin- angiotensin-aldosterone systemincreased capillary hydrostatic pressure

extravasation of fluid into the interstitial space

edemaEach explanation may be valid for some patients withNS, depending on their underlying renal disease or thestage of their disease at the time of study.

Edema(2)Edema(2)

Recent opinions:

Page 27: Nephrosis 2009,

Two factors offer at least partial explanation: Hypoproteinemia results in generalized liver protein sy

nthesis, including lipoproteins Lipid catabolism is decreased Two pathologic patterns: hypercholesterolemia alone and combined hypercholesterolemia and hypertriglyceridemiaIt plays a role in the hypercoagulable state, and may play

a role in the progression of glomerulosclerosis.

HyperlipidemiaHyperlipidemia

Page 28: Nephrosis 2009,

Clinical manifestations

Age: 75% of pediatric patients <6y at onset with peak age of onset between 2-3y.Sex: male: female = 2:1-3:2Eedema the major clinical manifestationLethargy, poor appetite, weakness, pallor, dia

rrhea and occasional abdominal pain.Hematuria and hypertension are unusual but

manifest in a minority of patients.

Page 29: Nephrosis 2009,

A presenting symptom in 95% of children with NSUsually begins insidiously with unexpected weight gain and early

morning periorbital swelling dependent areas (lower extremities, genitals and feet).

It can develop into generalized and marked edema (anasarca): inability to open the eyes.

ascites and pleural effusion respiratory distress. marked swelling in the abdomen, scrotal or labial areas prevents walking. decreased urine output.The edema is soft and pitting in nature.

EdemaEdema

Page 30: Nephrosis 2009,
Page 31: Nephrosis 2009,
Page 32: Nephrosis 2009,
Page 33: Nephrosis 2009,
Page 34: Nephrosis 2009,

Clinical classification Simple nephrosis hematuria Nephritic nephrosis azotemia hypertension

C3 Response to steroid therapy (prednisone 1.5~2mg/kg.d)

Complete response: urinary protein negative No response: + + + ~ + + + +

Partial response: + ~ + +

Classification

Page 35: Nephrosis 2009,

Only has the 4 major features of NS:

• massive proteinuria,

• hypoalbuminemia,

• marked edema,

• hypercholesterolemia.

Simple nephrosisSimple nephrosis

Page 36: Nephrosis 2009,

Besides the 4 major features of NS, also has one or more of the following features:

Hematuria: Increased RBCs (>10/HP) in urine are detected for several times (at least in 3 centrifuged urine specimens within 2 weeks)

Repeated hypertension: BP>130/90mmHg in shchool-aged patients, and >120/80 in preshchool-aged patients (not caused by corticosteroids)

Persistent azotemia: BUN>10.7mmol/L (not caused by hypovolemia)

Repeated or prolonged low serum levels of total complement(CH50)or C3

Nephritic nephrosisNephritic nephrosis

Page 37: Nephrosis 2009,

Differential between simple and nephritic nephrosis

Typical features Simple nephrosis Nephritic nephrosis

Age 2~7 yr, peak age is 3 yr School age

Edema Severe (ascites) Mild or moderate

Hyperlipidemia ↑↑ ↑Proteinuria + + + ~ + + + + ++ ~ +++

>50~100mg/kg/24hr <50mg/kg/24hr

Serum albumin ↓↓ Normal/slightly ↓Hematuria RBC < 10/HP RBC > 10/HP

Blood pressure Normal Raised

Complement C3 Normal Normal/low

Renal function Normal Abnormal

Histological type MCNS FSGS, MPGN

Prognosis well Bad

Page 38: Nephrosis 2009,

Complications

InfectionsHypovolemiaElectrolyte disturbancesHypercoagulability states andthrombosisAcute renal failure

Page 39: Nephrosis 2009,

The major complication Causes: decreased immunity (urinary loss of Ig and C) edema fluid acting as a culture medium immunosuppressive therapy protein deficiencyThe common infectious complications: bacterial sepsis, cellulitis, pneumonia, urinary tract infe

ctions and primary peritonitis.

InfectionsInfections

Page 40: Nephrosis 2009,

Causes: Hypoalbuminemia the plasma oncot

ic pressure loss of plasma water into the interstitial space and causing a decrease in circulating blood volume.

DiuresisSymptoms and signs: restlessness, cold hand

s and feet, delayed capillary filling, oliguria, tachycardia and Hypotension.

HypovolemiaHypovolemia

Page 41: Nephrosis 2009,

• Causes:

Limitations of diet

Poor intake

GI loss (vomiting and diarrhea)

Diuresis

hyponatremia, hypokalemia, hypocalcemia

Electrolyte disturbancesElectrolyte disturbances

Page 42: Nephrosis 2009,

Causes: Urinary loss of anti-coagulant proteins Hemoconcentration and hypovolemia Hyperlipidemia (increased viscosity) and increased platelet ag

gregation Elevated coagulation factors

Renal vein thrombosis is more commonPulmonary or cerebral embolism life-threatening

Avoidance of bed rest, volume depletion, diuretics and deep venous or arterial punctures to prevent embolism.

Hypercoagulability states and thrombosis

Hypercoagulability states and thrombosis

Page 43: Nephrosis 2009,

• Is more often precipitated by hypovolemia

• Reduction in the glomerular filtration rate has also been hypothesized

Acute renal failureAcute renal failure

Page 44: Nephrosis 2009,

Laboratory findings 1. Urinalysis Proteinuria: Protein: qualitatively +++~++++ quantitatively >0.1g/kg.d. The ratio of urinary protein to urinary creatinine: >2 Hematuria RBC may be increased in nephritic- nephrotic syndrome Occasionally appears in simple nephrosis

Page 45: Nephrosis 2009,

2. Blood: Hypoalbuminemia: albumin < 10g~20g/L Hyperlipidemia: cholesterol > 5.7mmol/L ESR > 100mm/h In nephritic-nephrotic syndrome, renal functions and serum complement 3 may be reduced. Serum electrolyte determination: to evaluate hyponatremia, hypokalemia, hypocalcemia

Page 46: Nephrosis 2009,

Diagnosis The criteria of diagnosis: Massive proteinuria: Urinalysis reveals 3+ or 4+. Protein excr

etion exceeds 100mg/kg.d. Hypoalbuminemia: The serum albumin level is generally less t

han 30g/L (usually 10g~20g/L) Hypercholesterolemia: the serum concentration of cholesterol i

s > 5.7mmol/L Edema with various degrees The first two items are the most necessary for diagnosis The diagnosis of different clinical types of NS

Page 47: Nephrosis 2009,

Differential diagnosis

Primary NS should be differentiated from secondary NS or GN with nephrotic picture, such as HSP nephritis, SLE nephritis, APSGN.

Page 48: Nephrosis 2009,

Treatment(1)

• General measures

Activity

Diet

Diuretic therapy

Treatment of complications

Page 49: Nephrosis 2009,

• Do not restrict activity unless the patient is severely edematous or with severe hypertention or infections.

• To prevent thrombosis, patients restricted to bed rest should change position frequently.

ActivityActivity

Page 50: Nephrosis 2009,

• The diet should provide adequate energy (calorie) intake and adequate protein (1-2 g/kg/d).

• Sodium restriction (Low sodium or no sodium diet) is indicated for patients with edema or hypertension, but should be adjusted according to the serum levels of sodium. Long-term sodium restriction is not recommended.

• Fluid restriction is required when the edema is severe with oliguria.

• Replacement of vitamins and minerals.

DietDiet

Page 51: Nephrosis 2009,

Diuretic is indicated when edema is severe, esp. with ascites. It can be used for symptomatic relief until steroid diuresis occurs Hydrochlorothiazide(HCT): 2-4mg/kg.d Antisterone: may be added if HCT is not effective. Salt-poor albumin at 0.5~1g/kg iv, over 1 hr (when serum albu

min<20g/L), followed by iv injection furosemide 1-2mg/kg.dose . Multiple use is not recommended.

A renal blood vessel dilator should be given (dopamine 2~4 μg/kg.min) in patients with refractory edema, combined with furosemide.

Hypovolemic shock or postural hypotension should be monitored during diuresis.

Diuretic therapyDiuretic therapy

Page 52: Nephrosis 2009,

Anti-infection: antibiotics that cover both gram-positive and negative organisms should be given; But continuous prophylactic antibiotics are not recommended.

Anti-coagulation therapy: heparin, persantin, exercise of extremities, et al.

Therapy for electrolyte disturbance.

Treatment of complicationsTreatment of complications

Page 53: Nephrosis 2009,

Treatment(2)

• Specific therapy

Glucocorticoid therapy

Cytotoxic agent therapy

Pulse therapy

Page 54: Nephrosis 2009,

At initial diagnosis, Prednisone or Prednisolone oral therapy is the first line:

• Before starting steroid therapy, a tuberculin skin test should be done.

• Medium-long term prednisone therapy Short term prednisone therapy• NS types classified by response to steroid therapy• Adverse effects of long term corticosteroid treat

ment

Glucocorticoid therapyGlucocorticoid therapy

Page 55: Nephrosis 2009,

Medium-long term prednisone therapy

• Commonly used in China, including 3 phases:1. 2mg/kg/d (maximum 60 mg/day) tid, until the proteinuria has

dissappeared for 2 weeks Remission can be achieved during this phase in most children with PNS, th

en entered the next phase If remission isn’t achieved, continue the initial dosage, but not over 8 weeks

before entered the next phase.

2. 1.5- 2mg/kg, qod (single dose, every other morning, alternate-day therapy) for another 4 weeks.

3. Reduced by 2.5~5 mg q2-4w until stopped.• Medium term therapy: total course is 6m• Long term therapy: total course is 9~12m

Page 56: Nephrosis 2009,

Short term prednisone therapy

• Prednisone dosage at:

1. 2mg/kg/d (maximum 60 mg/day) tid, for 4 weeks

Regardless of the responses, entered the next phase.

2. 1.4mg/kg, qod for another 4 weeks, then stopped.• The total therapy course is 8~12 weeks.• May be associated with a higher rate of early rec

urrence or relapse.

Page 57: Nephrosis 2009,

Steroid sensitive NS: Complete remission is achieved within the first 8 w of the initial steroid therapy.

Partialy steroid sensitive NS: After 8w of the initial steroid therapy, edema subsides, but urinary protein is still +~++.

Steroid resistant NS: Failure to achieve remission (urinary protein +++) in spite of 8 weeks of standard prednisone therapy.

NS types classified by response to steroid therapy(1)

Page 58: Nephrosis 2009,

Steroid dependent NS: Patients who has 2~3 consecutive relapses occurring during the period of steroid taper or within 14 days of its cessation is defined as…

Relapse or recurrence: Patients who has urinary protein++ after 4w of steroid cessation or during maintenance

Frequent relapses or recurrences: Patients who has 2 or more relapses or recurrences within 6 months, or 3 within 12 months is said to have …

NS types classified by response to steroid therapy(2)

Page 59: Nephrosis 2009,

Adverse effects of long term corticosteroid treatment

• Cushingoid features (obesity, round face, striae) • Increased susceptibility to infections • Hypertension• Osteoporosis• Hypokalemia • retarded growth• Cataracts• Peptic ulcer disease • Diabetes mellitus

Page 60: Nephrosis 2009,

Cyclophosphamide, cyclosporine, chlorambucil, nitrogen mustard…

Indication: Intractable NS (steroid resistance, frequent rela

pses or recurrences) Steroid dependent NS with signs of steroid toxic

ity.The adverse effects: sexual gland damage; bone

marrow depression; hemorrhagic cystitis; nausea, vomitting, gastritis; alopecia; liver damage.

Cytotoxic agent therapyCytotoxic agent therapy

Page 61: Nephrosis 2009,

Methylprednisolone: 15~30 mg/kg.d (<1.0g/d) add 10% gluc

ose 100~250 ml in drip, for 3 days. Repeated same as above every 1~2 weeks if necessary.

CTX: 0.5~0.75g/m2 in drip, once monthly, for

6 months if necessary.

Pulse therapyPulse therapy

Page 62: Nephrosis 2009,

Prognosis(1)

Varies depending on the histological type>90% of MCNS respond to corticosteroid therapy Only 30% of children never have a relapse after

the initial remission approximately 50% have 1-2 relapses within 5

years 20% continue to relapse 10 years after diagnosis Approximately 3% of patients who initially

responded to steroids become steroid resistant.

Page 63: Nephrosis 2009,

• Only approximately 20% of patients with FSGS undergo remission of proteinuria

• Approximately 50% of patients with MsPGN undergo complete remission of proteinuria during steroid therapy

• MPGN has the most worse prognosis. no difference was evident in the outcome between treated and untreated patients;

Prognosis(2)

Page 64: Nephrosis 2009,

Indications of renal biopsy

• Unsuccessful therapeutic trial of steroids : Steroid resistance Frequent relapses or steroid dependency• A child >10y at onset• Coexistence of significant hematuria, hyp

ertension, azotemia and depressed serum C3 at onset.

• Secondary causes of nephrotic syndrome.

Page 65: Nephrosis 2009,

Keys to be remembered

Type of NS

Five morphologic patterns of PNS

Pathophysiology of 4 feturesClassification including the table of differ

ential between simple and nephritic nephrosis

ComplicationsThe criteria of diagnosis